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Summary of Key Points (35 words): One in five admissions to a healthcare institution for 
MRSA or VRE are based on data from a different healthcare system.  A regional patient registry 
and electronic admission notifications can facilitate coordinated infection prevention efforts.    
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Abstract 
Background. We developed and assessed the impact of a regional antimicrobial resistance 
(AMR) patient registry and electronic admission notification system on regional AMR infection 
rates over time.  We conducted an observational cohort study of all patients identified as infected 
or colonized with Methicillin-resistant Staphyloccus aureus (MRSA) and/or Vancomycin-
resistant enterococci (VRE) on at least one occasion by any of five healthcare systems between 
2003 and 2010.  The five healthcare systems included a total of 17 hospitals and associated 
clinics in the Indianapolis, Indiana region. 
Methods. We developed and standardized a registry of MRSA and VRE patients and created 
web forms for infection preventionists (IPs) to maintain the lists. We generated email alerts to 
IPs whenever a patient previously infected or colonized with MRSA or VRE registered for 
admission to a study hospital from June 2007 through June 2010. 
Results. Over three years, we delivered 12,748 email alerts on 6,270 unique patients to 24 IPs 
covering 17 hospitals. One in five (22-23%) of all admission alerts were based on data from a 
healthcare system different than the admitting hospital; a few hospitals accounted for most of this 
cross-over between facilities and systems. 
Conclusions. Regional patient registries identify an important patient cohort with relevant prior 
antibiotic-resistant infection data from different healthcare institutions. Regional registries can 
identify trends and inter-institutional movement not otherwise apparent from single institution 
data.  Importantly, electronic alerts can notify of the need to isolate early and to institute other 
measures to prevent transmission. 
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Introduction: 
Methicillin-resistant Staphyloccus aureus (MRSA) and Vancomycin-resistant enterococci (VRE) 
are two common antibiotic resistant bacteria in healthcare settings.[1, 2]  The majority of studies 
on MRSA and VRE derive from single institutions, however, there is increasing recognition of 
the role of inter-facility spread of infections, particularly in regions with multiple health care 
facilities.[3-5] 
To better monitor regional rates and track the spread of antibiotic resistant bacterial infections, 
we built and embedded an AMR registry and tracking system within a regional health 
information exchange, to register all known MRSA and VRE cases and identify when these 
patients were admitted to any health care facility within the region.[6] Since May of 2007, we 
have actively shared information on patient MRSA and VRE colonization or infection status 
between all major hospitals in Indianapolis and generated e-mail alerts when patients with a 
history of either are admitted to a hospital.[7]  Here we describe initial findings from our 
citywide network.   
 
Methods: 
This study was conducted in Indianapolis, Indiana and included all Indianapolis hospitals 
participating in the Indiana Network for Patient Care (INPC) at the time the project began.[8]  
The INPC is an example of an operational Health Information Exchange (and in recent years has 
expanded beyond the original five hospital systems).  This study involved the five major hospital 
systems (17 total hospitals) in the Indianapolis (Marion County) area. The INPC has stored more 
than one billion data elements from the Indianapolis region, and more than 85% of the 
population in Marion County has some data in the system.[9, 10]  
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We previously described creation of a regional infection control network tying together Infection 
Preventionists (IPs) between the five hospital systems in Indianapolis.[6] We created a common 
means for IPs to identify MRSA and VRE cases and to update information on cases as necessary.  
In mid-May 2007, we instituted email alerts to notify infection control personnel when a patient 
with a history of MRSA or VRE infection or colonization presented for admission at 
participating hospital systems. If a patient had both MRSA and VRE in their history, a separate 
email alert for each was sent at the time of admission.  For analysis we included data from June 
1, 2007 through June 1, 2010 to include only full months.   A simplified flow diagram (Figure 1) 
outlines the process for generating an email alert.  Our system leveraged two key components of 
the INPC; a robust enterprise master patient index to uniquely link patients across institutions  
and the transmission of a standardized electronic message (an Admission/Discharge/Transfer or 
ADT message using the HL7 standard) whenever a patient was admitted to any participating 
institution.[11]   The HL7 messaging standard is used in virtually all health systems, and ADT 
messages in particular are commonly generated at the time of patient registration within 
emergency departments.[12]     
We “primed” the system with existing lists of patients with prior history of colonization or 
infection with MRSA or VRE from all participating institutions, as recorded by their infection 
control teams.  Our system recorded the initial laboratory result as entered by the IP, the source 
institution, and the culture site which prompted entry of the patient into the merged citywide list 
of MRSA/VRE cases.  We similarly recorded the date/time and location of subsequent 
admissions of registry patients.  Patients could be removed from the citywide list by any 
infection control provider documenting that the patient had been “cleared.”  Each site used its 
institution’s criteria to make this determination.   
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Although the standardized web forms included a “pick list” (or “drop-down menu”) of the most 
common culture sites, IPs could use free text entry to describe the culture site in greater detail, or 
to overwrite an option on the list.  We therefore reclassified all free text entries as one of the 
common culture sites where possible (e.g. blood, skin and soft tissue, urine, stool, sputum).  For 
patients with more than one positive culture site, we included all cultures sites for analysis.  We 
analyzed patients who had MRSA or VRE or both during the time period of the study.    
We created network diagrams to illustrate the connectivity between study hospitals using the 
open source GraphViz software.  [13]  Network diagrams can be used to visualize connections 
(edges) between entities (nodes) with applications in social network analysis or data flow 
diagrams.  In this study, we used Graphviz software to visualize the flow of patients between 
institutions.  We visualized nodes as circles, with area proportional to the number of unique 
patients identified with MRSA or VRE and admitted only within the same institution.  We 
visualized edges or connections between the institutions with the width of the arrows 
proportional to the unique patients identified with MRSA or VRE at one institution, but later 
admitted to a different institution (“crossover” patients).   
We compared age, gender, and race for admitted “crossover” patients versus patients who were 
admitted within the same institution.  We used two-sample t-tests to compare mean ages between 
groups, and chi-square tests to compare gender and race.  Missing values were negligible for age 
and gender.  Missing race could not be imputed based on available data and was not included in 
tests of comparison.   
At 18 months after alerts went live, we surveyed IPs at all five participating hospital systems to 
determine overall burden of alerts, gauge perceived usefulness of the system, estimate time cost 
or savings in using the alerting system, and elicit suggestions for improvement.   
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From November, 2006 to February, 2008, one of the investigators (BND) led an AHRQ-funded 
project aimed at reducing MRSA infection and transmission in hospitals.[14, 15]  We formed a 
regional collaborative to spread effective strategies for Methicillin-resistant S. aureus (MRSA) 
reduction, identify strategies for reducing healthcare associated, community onset (HACO) 
MRSA, and build a network of people/organizations devoted to MRSA prevention.  They 
conducted a two-phase project, in order to identify and spread successful strategies for reducing 
MRSA infections in hospitals.  The first phase involved four hospitals in Indianapolis over two 
years. The second phase beginning in mid-2009, was a multisite, multihospital quasi-
experimental study of seven hospital systems, including four systems in Indianapolis over four 
years. 
Doebbeling and colleagues also worked closely with hospital leaders and front-line staff in 
inpatient units to apply organizational changes strategies and evidence-based infection 
prevention precautions. As part of this project, an intervention bundle was implemented in 4 of 
the 5 Indianapolis hospital systems. The intervention bundle consisted of active surveillance 
cultures (including nasal swabs) for all patients admitted to study units, pre-emptive barrier 
isolation of those identified as either infected or colonized with MRSA, and institution of strict 
hand-hygiene before and after each patient contact.   
 
Results: 
From 2003-2010, the registry included 23,776 unique patients infected or colonized with MRSA, 
3,036 unique patients with VRE, and an additional 914 unique patients with both MRSA and 
VRE (Table 1).  Data on race was missing for 19% of the study cohort.   
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From June 1, 2007 to June 1, 2010, we delivered 12,748 email alerts on 6,270 unique patients 
(Table 2).  As with the larger cohort, race data was missing for a significant proportion (29%).  
Patients admitted with a history of MRSA colonization or infection were, on average, older than 
the overall cohort with a history of MRSA colonization or infection (57.0 vs 46.4 years).  The 
same was true among those who had a history of both MRSA and VRE (58.9 for admitted 
patients vs 51.6 years for all patients). 
In twenty-three percent of admissions of patients with a previous history of MRSA, the MRSA 
had been identified at a hospital system different from the admitting hospital (range 19% to 30% 
of the admissions each year, over the three years).  For VRE, this rate was 22% (range 15% to 
35%).  Patients in the MRSA group who were admitted to a hospital system different from where 
the MRSA information had been entered into the registry (“crossover” patients) were younger 
(54.8 vs 57.7 years, p<0.001), and more often female (55% vs 50%, p value = 0.003) than 
patients who stayed within the same system (Table 3).  Patients with a history of VRE admitted 
to a hospital system different from where VRE had been entered into the registry were similar in 
age to patients who stayed within the same system, and were more likely to be female (73% vs 
59%, p value = 0.004).  Patients with a history of both MRSA or VRE admitted to a hospital 
system different from where MRSA and VRE had been entered into the registry were more 
likely, compared to those who stayed within the same hospital system, to be black (38% vs 26%, 
p = 0.01), although race was missing for 17.6% of admitted patients.   
Evaluating only the cohort of new patients since the start of email alerts (N= 4016), we observed  
that email admission alerts occurred  an average of 135 days after the patient was first identified 
as having MRSA or VRE in the registry (SD= 181) with a median of 57 days, and 60% of all 
alerts occurred within 365 days after the MRSA or VRE data had been first entered into the 
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registry.  The maximum number of alerts across all participating hospitals in any one day was 29, 
with a maximum of 10 for a single hospital.   
Of all patients who generated an alert, 57% had only a single alert over the 3 years, 87% had 3 or 
fewer, and 99% had 9 or fewer.  Sixty-eight patients generated 10 or more alerts, with one 
patient generating an alert at 47 distinct hospital admissions.      
We created network diagrams indicating the flow of patients from initial site of identification of 
colonization or infection with MRSA or VRE, to sites of subsequent admissions (Figure 2 and 
3).  Every institution shared patients with every other institution, serving both as a source, and as 
a receiver, of patients.  Different institutions accounted for the highest number of total 
admissions.   
From 2003 to 2006, rates of positive cultures for skin and soft tissue sites (SSTI) increased 
steadily as a proportion of total MRSA positive cultures (Figure 4).  From 2006 until 2010, rates 
of all MRSA positive culture sites decreased, with sites associated with SSTIs decreasing most 
rapidly.   Over the same years, rates of positive nasal cultures increased rapidly, coincident with 
regional implementation of the infection control bundle.  Over the same time period, rates of 
SSTI, blood stream, and urinary tract culture sites positive for VRE steadily increased (Figure 5).   
Ten IPs representing all of the five institutions completed a subsequent survey at 18 months post 
go-live.  All responded yes to the question, “Do you find the email alerts useful?”  IPs estimated 
an average alert burden of five email alerts per day, of which just over half (55%) were already 
known to them from data at their own institution.  The most common reasons for how IPs used 
the alerts were to identify patients requiring intervention (e.g. contact isolation), and to identify 
MRSA cases coming from outside institutions.   In considering the time cost of the alerting 
system (emails and data entry), 6 IPs considered the system to be time neutral overall, 3 
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responded that use of the system added time, and one responded that the system overall was a 
time saver.  The most common recommended improvements to the system were automated 
capture of laboratory data into the system to reduce burden of manual entry of new cases.   
 
Discussion: 
Since May 2007, Indianapolis infection preventionists have used a common system to 
collectively track over 20,000 unique patients with a history of infection or colonization with 
MRSA or VRE.  Our network enabled IPs at participating institutions to benefit from the 
collective infection history of shared patients while continuing to maintain their own historical 
records.  There have been a number of successful regional efforts to coordinate and implement 
regional infection control, although to our knowledge, ours is the first to implement admission 
alerts regionally.[16-18]   
Alerts based on regional data identified when a patient with a history of infection or colonization 
with a drug resistant organism was readmitted to any networked institution and may improve 
rates of compliance with contact precautions.[19]  In this study, we demonstrated that 
approximately one in five patients with a relatively recent history of MRSA or VRE is 
readmitted at neighboring institutions, which corroborates and quantifies the estimates of other 
studies.  [3-5, 20]  Although we cannot directly relate our regional admission alerts to improved 
infection control measure compliance, our regional registry captured data likely reflecting 
compliance with increased surveillance cultures (nasal) as part of a coordinated effort to reduce 
MRSA infections.  Recent models suggest that coordinated infection control efforts in a region 
can help individual hospitals achieve better control than on their own.[21] 
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Universal screening has been proposed as an effective means to control MRSA infections.[22]  
However, controversy remains over the optimal approach given variation in how well infection 
control measures are implemented and the significant resource investment required.[23-25]  In 
this example, data sharing on prior history of infection or colonization with MRSA or VRE may 
have reduced the need for repeat culture, and more quickly identified a patient requiring pre-
emptive contact precautions. Our data demonstrate that local hospital interactions are 
asymmetric, with some hospital systems sharing a disproportionate burden of infected or 
colonized patients.  Identification of higher burden hospitals or hospital systems may help guide 
resources to match relative burden of disease in a community. Institutions also differed in their 
relative burden of MRSA versus VRE patients.  Further study may elucidate institutional factors 
associated with differing rates of drug-resistance.[26]    
Creation of a common registry enabled regional tracking of new cases of MRSA or VRE.  
During the study period, the incidence of positive cultures involving skin and soft tissue sites 
increased disproportionately, likely mirroring the increase in CA-MRSA cases noted both locally 
and nationally.[27, 28]  Overall rates of positive MRSA blood cultures decreased gradually over 
the same time period (a finding similar to that of other studies), although MRSA positive blood 
culture rates increased slightly at individual institutions.[29]  These changes may also have 
reflected an aggressive program of active surveillance and interventions to reduce hospital-based 
MRSA instituted during the study period.  Notably, however, rates of positive VRE cultures did 
not change and in fact, trended upwards for urinary tract sites.   
Regional surveillance of drug resistant infections provides a broader and potentially more 
accurate view of infection burden than data from a single institution, and can help coordinate the 
appropriate use of limited infection prevention resources.  Our system reflected national trends in 
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MRSA incidence and documented evidence of dedicated active surveillance efforts, and potential 
effects of these efforts on subsequent infection rates.   
There are several limitations to our study.  We designed our system to capture data entered and 
verified by IPs, rather than data directly from the laboratory information systems, based on 
preliminary work that automating case capture could not be considered 100% reliable. As a 
result, entry dates for new cases sometimes lagged behind the actual time when the infection or 
colonization was recognized, depending on when the IP was able to manually enter the case 
information.  The requirement for  human review and entry into our standardized web forms, 
likely increased administrative burden on IPs.  In fact, the IPs in one of the hospital systems 
stopped entering data into the system in 2011.  However, for the 2007-2010 study period, the 
system was in continuous use by IPs, which suggests that the benefits of the system may have 
outweighed (or may have been in approximate balance with) the additional burden of data entry, 
a fact supported by our mid-study survey.  During the time of the study, molecular typing for 
MRSA strains was not routinely conducted, and neither the hospitals nor the INPC reliably 
electronically captured enough additional information, in one place, to classify MRSA cases as 
Healthcare-associated (HA), Community-associated (CA), or Healthcare-associated Community 
Onset (HACO) classification according to the CDC clinical categories.[1]  Instead, our system 
triggered alerts based on any prior history of MRSA or VRE regardless of classification, or when 
the original infection or colonization took place.  IPs could remove a patient from the regional 
listing, but may not have done so consistently.  The majority of alerts (60%) were triggered 
based on historical data from within one year of the admission date, and limiting alerts to trigger 
based on no more than a one-year window may reduce the risk of excess alerts or alert 
fatigue.[30]   
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For this study we tracked only cases of MRSA and VRE.  We recently expanded our focus to 
include infection or colonization with gram negative organisms, recognizing that multi-drug 
resistance in these organisms poses an impending threat.[31-33]  To reduce the burden on IPs of 
manual entry of cases, we are developing the means to extract structured data on new infections 
directly from electronic messages generated by the laboratory information systems, to limit 
manual entry only to unusual or uncertain cases.    
In this work we successfully implemented a system to track and coordinate infection control 
efforts within an operational regional health information exchange.  Although we benefited from 
a longstanding history of pioneering informatics work within Indianapolis, recent trends suggest 
that our work may be generalizable to other communities.[34]  Government initiatives to 
stimulate adoption of EHRs have yielded early success, with steady increase in EHR use 
nationally.[35, 36]  Federal regulations outlining the “Meaningful Use” of EHRs may improve 
the quality and structure of data captured in EHRs for research or public health purposes.[37, 38]  
With increased adoption and improved use of EHRs, efforts to connect systems through  local 
and regional health information exchanges are increasingly widespread, although significant 
barriers still remain.[39]   Our work represents a specific use case within a functioning HIE, but 
one that leverages technology and standards commonly used in health systems and other HIEs 
(e.g. an enterprise master patient index and HL7 ADT messages generated at admission).  With 
the increasing implementation of EHRs and HIEs, other communities may be well positioned to 
develop similar electronically coordinated infection control efforts.    
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Table 1: Demographics of the patients in the cohort (2003-2010) with MRSA or VRE 
 
    MRSA  VRE  Both 
    N  %  N  %  N  % 
Race  White  13212 55.6 2035 67 579 63.3 
   Black  4842 20.4 521 17.2 188 20.6 
   Other  846 3.6 89 2.9 11 1.2 
   Missing  4876 20.5 391 12.9 136 14.9 
                  
Gender  Female  11663 49.1 1822 60 505 55.3 
   Male  12096 50.9 1214 40 407 44.5 
   Unknown  17 0.1 0 0 2 0.2 
                 
Age  Under 18  2595 10.9 23 0.8 17 1.9 
   18 to 35  4518 19 213 7 95 10.4 
   35 to 64  9341 39.3 1408 46.4 446 48.8 
   65 and over  6967 29.3 1343 44.2 347 38 
   Missing  355 1.5 49 1.6 9 1 
               
                       
Age  mean  46.4 
 
60.8 
 
51.6  
   median  48 
 
62 
 
55.5  
   std  24.5   17 
 
24.5  
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Table 2: Demographics of the patients admitted (6/2007 – 6/2010) with a history of MRSA 
or VRE infection or colonization 
    MRSA  VRE  Both 
    N  %  N  %  N  % 
Race  White  2414 49.7 435 64.1 424 57.8 
  Black  783 16.1 103 15.2 175 23.8 
  Other  91 1.9 19 2.8 6 0.8 
  Missing  1569 32.3 122 18 129 17.6 
   
         
 
               
Gender  Female  2503 51.5 414 61 406 55.3 
  Male  2354 48.5 265 39 328 44.7 
               
Age  Under 18  110 2.3 0 0 1 0.1 
  18 to 34  610 12.6 45 6.6 64 8.7 
  35 to 64  2287 47.1 340 50.1 390 53.1 
  65 and 
over 
1849 38.1 294 43.3 279 38 
                   ( 1 age missing in MRSA group) 
 
Age  mean  57 
 
61.1 
 
58.9   
  median  58 
 
61 
 
60   
  sd  19.6 
 
16.1 
 
15.9   
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Table 3.  Demographics of “crossover” patients vs. patients staying within same hospital 
system 
 
 
MRSA 
n=4857 
VRE 
n=679 
Both 
n=734 
 
Crossover Same 
P-
value 
Crossover Same 
P-
value 
Crossover Same 
P-
value 
Age in 
years   54.8 57.7 
<.001 62.1 60.1 .48 58.6 59.0 .75 
% 
Female  
n  
55.4  50.3  
.003 72.9 58.5 .004 63.0 52.3 .01 
% 
Black   
 
24.0 23.8 .92 19.4 18.4 .87 38.3 26.1 .01 
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Figure Legends: 
Figure 1.  Flow diagram outlining process of generating regional email alerts upon hospital 
admission for patients previously infected or colonized with MRSA or VRE.   
Figure 2: Directed graph of admissions for patients with a history of MRSA infection or 
colonization who stayed within a hospital system (circles or nodes) or who crossed over 
between hospital systems (arrows or edges).   
Figure 3: Directed graph of admissions for patients with a history of VRE infection or 
colonization who stayed within a hospital system (circles or nodes) or who crossed over 
between hospital systems (arrows or edges).   
Figure 4: Counts of positive MRSA culture sites by year. 
Figure 5: Counts of positive VRE culture sites by year. 
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